SEC Form D private-offering filing

Invea Therapeutics, Inc

Name: Invea Therapeutics, Inc - new SEC Form D private-offering filing, Guilford, CT
Published: 2025-12-10

A new SEC Form D private-offering notice from Guilford, CT, a $120,250 filer-stated offering target in Biotech. The source filing is one click away.

Invea Therapeutics, Inc site↗ Verified via SEC Form D

Biotechnology company developing oral small molecule therapeutics for immune mediated inflammatory diseases such as atopic dermatitis and chronic urticaria.

Filed 2025-12-10Filed to raise $120,250First money in 2025-10-31Raised so far $120,250HQ (as filed) Guilford, CTSector Biotech ✓Stage (inferred) Pre-seedCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified inveatx.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Connecticut →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.